LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Search

Illumina Inc

Fermé

Secteur Soins de santé

124.18 -4.18

Résumé

Variation du prix de l'action

24h

Actuel

Min

123.96

Max

125.38

Chiffres clés

By Trading Economics

Revenu

-1.9B

-2B

Ventes

30M

1.1B

BPA

0.36

Marge bénéficiaire

-179.099

Employés

10,590

EBITDA

-1.9B

-1.9B

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+20.11 upside

Dividendes

By Dow Jones

Prochains Résultats

7 nov. 2024

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

21B

Ouverture précédente

128.36

Clôture précédente

124.18

Sentiment de l'Actualité

By Acuity

34%

66%

107 / 365 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Very Strong Bearish Evidence

Illumina Inc Graphique

Actualités Associées

11 déc. 2023, 18:43 UTC

Acquisitions, Fusions, Rachats

Illumina Submits SEC Form For Grail Divestiture

13 oct. 2023, 18:42 UTC

Acquisitions, Fusions, Rachats

Illumina Gets European Commission Order to Divest Grail

5 mars 2024, 08:00 UTC

Résultats

Earnings Season Is Wrapping Up. Who Came Out Ahead, in 6 Charts. -- Barrons.com

18 déc. 2023, 23:17 UTC

Acquisitions, Fusions, Rachats

Antitrust Regulators Issue New Merger Rules Amid Crackdown -- Barrons.com

18 déc. 2023, 20:33 UTC

Acquisitions, Fusions, Rachats

Adobe-Figma Breakup Isn't Just a Win for Regulators. Why Consumers Should Be Cheering Too. -- Barrons.com

18 déc. 2023, 09:48 UTC

Acquisitions, Fusions, Rachats

Illumina to Sell Grail. It's Giving Up on its Biotech Antitrust Battle. -- Barrons.com

18 déc. 2023, 09:34 UTC

Acquisitions, Fusions, Rachats

These Stocks Are Moving the Most Today: Illumina, Roku, Uber, Broadcom, and More -- Barrons.com

9 nov. 2023, 09:39 UTC

Résultats

These Stocks Are Moving the Most Today: Disney, Arm, Applovin, Affirm, Topgolf Callaway, and More -- Barrons.com

Comparaison

Variation de prix

Illumina Inc prévision

Objectif de Prix

By TipRanks

20.11% hausse

Prévisions sur 12 Mois

Moyen 149.4 USD  20.11%

Haut 242 USD

Bas 105 USD

Basé sur 20 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

20 ratings

12

Achat

7

Maintien

1

Vente

Score Technique

By Trading Central

N/A / 130.15Support & Résistance

Court Terme

Very Strong Bearish Evidence

Moyen Terme

Strong Bullish Evidence

Long Terme

Bullish Evidence

Sentiment

By Acuity

107 / 365Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Illumina Inc

Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions. The Company operates through segments such as Core Illumina. Core Illumina’s products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. Core Illumina consists of its core operations. The Company's portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed for genetic analysis. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies.